American Health Packaging Recalls Pramipexole Dihydrochloride Tablets Due to GMP Deviations
American Health Packaging is recalling Pramipexole Dihydrochloride Tablets due to GMP deviations and possible cross-contamination from cleaning failures.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II, which corresponds to a severity score of 4 (Severe) per the rubric, as it may cause temporary or medically reversible adverse health consequences.
Plain-English summary
American Health Packaging is recalling Pramipexole Dihydrochloride Tablets, 1.0 mg, 30 Tablets (6 tablets per blister card), Rx Only. The recall involves 6,643 cartons distributed nationwide in the United States. The affected lots are 176179, 176616, 178562, 179947, 182048, 183136, and 184217, with expiration dates ranging from May 31, 2019, to August 31, 2020.
The recall was initiated due to Good Manufacturing Practice (GMP) deviations and the possibility of cross-contamination of the product resulting from a cleaning procedure failure. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers and healthcare providers should stop using the affected lots of Pramipexole Dihydrochloride Tablets and contact their healthcare provider for guidance on alternative treatment options. The recalling firm, American Health Packaging, is responsible for managing the recall and providing further information to affected parties.
The recalled product
- Product
- Pramipexole Dihydrochloride Tablets, 1.0 mg, 30 Tablets (6 tablets per blister card), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC Blister Card: 68084-982-95; NDC Carton: 68084-982-25
- Manufacturer
- American Health Packaging
- Category
- Drug — Prescription Medication
- Affected units
- 6,643
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot
- expiry: Lot 176179
- exp 05/31/2019
- Lot 176616
- exp 07/31/2019
- Lot 178562
- exp 09/30/2019
- Lot 179947
- exp 12/31/2019
- Lot 182048
- exp 04/30/2020
- Lot 183136
- exp 06/30/2020
- Lot 184217
- exp 08/31/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by American Health Packaging under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · American Health Packaging
See all →- ModerateNitrofurantoin Capsules 100 mg recalled for failed dissolution specifications
FDA (Drugs) · 2022-05-25
- ModerateCyanocobalamin Injection Recalled Due to Subpotency and Assay Non-Compliance
FDA (Drugs) · 2022-05-04
- SevereOxycodone Hydrochloride Oral Solution Recall Due to Impurity Failure
FDA (Drugs) · 2022-03-16
- ModerateMetoprolol Succinate ER Tablets Recall for Failed Dissolution
FDA (Drugs) · 2022-02-02
- ModerateGlipiZIDE Extended-Release Tablets 2.5 mg Nationwide Recall
FDA (Drugs) · 2021-10-27
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27